U.S. Semiconductors Stock News

Frontdoor, Inc. ( NASDAQ:FTDR ) shareholders might be concerned after seeing the share price drop 10% in the last...

In January 2026, Gevo announced a leadership realignment including the appointment of Alex Clayton as Chief Carbon Officer and highlighted that its North Dakota facility has issued over 500,000 engineered carbon dioxide removal certificates, which are certified for thousand-year permanence. This push into high-integrity carbon removal credits, supported by third-party ratings and the Puro Standard, underpins Gevo’s ambition to be a key player in the voluntary carbon markets. We’ll now...

Roper Technologies (ROP) has wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$4.00, alongside net income of US$428.4 million. The company has seen quarterly revenue move from US$1.88 billion in Q1 2025 to US$2.1 billion in Q4 2025. Quarterly basic EPS has ranged from US$3.08 to US$4.00 over the same period, giving investors a clear view of how the top and bottom line have tracked together through the year. With trailing 12 month net profit margin at 19.4%...

Wondering if StandardAero is priced fairly right now or if the market is missing something? This article explains what the current share price might be suggesting about its value. StandardAero shares recently closed at US$33.12, with returns of 3.4% over 7 days, 13.6% over 30 days, 11.7% year to date, and 27.2% over the last year, which may catch the eye of investors watching for changing risk and reward. Recent coverage around StandardAero has focused on its position in the capital goods...

If you have been wondering whether Terex stock is offering good value right now, the numbers behind its current price can tell you a lot about what you are really paying for. Terex recently closed at US$60.47, with returns of 2.5% over the last 7 days, 9.6% over the last month, 9.9% year to date and 30.3% over the last year, as well as 23.4% over 3 years and 76.6% over 5 years. These figures may shape how investors view both potential upside and risk today. Recent coverage around Terex has...

Despite an already strong run, Mirum Pharmaceuticals, Inc. ( NASDAQ:MIRM ) shares have been powering on, with a gain of...

The board of U.S. Global Investors, Inc. ( NASDAQ:GROW ) has announced that it will pay a dividend of $0.0075 per share...

As the U.S. stock market experiences a period of modest gains, with major indices like the S&P 500 reaching new milestones and investors anticipating key decisions from the Federal Reserve, attention turns to identifying opportunities within this evolving landscape. In such an environment, discerning undervalued stocks can be crucial for investors aiming to capitalize on potential market inefficiencies and intrinsic value disparities.

As the U.S. market experiences a slight uptick with major indices like the S&P 500 reaching new milestones, investors are keenly observing how upcoming Federal Reserve decisions and tech earnings will impact future trends. In this environment, growth companies with high insider ownership often attract attention, as their alignment of interests between insiders and shareholders can be appealing amid fluctuating market conditions.

As the U.S. stock market edges higher with the S&P 500 reaching new milestones, investors are keenly watching for signals from the Federal Reserve and major tech earnings that could influence future trends. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. Though considered a niche area, these stocks can shine when backed by solid financial health and fundamentals,...

As the United States market navigates a period of cautious optimism with key indices like the S&P 500 reaching new heights, investors are closely watching for signals from the Federal Reserve and major tech earnings. Amidst this backdrop, small-cap stocks often present unique opportunities for those looking to explore lesser-known companies that could benefit from broader economic trends and sector-specific catalysts.

As the U.S. stock market continues to edge higher, with the S&P 500 reaching new milestones and investor attention focused on Federal Reserve decisions and major tech earnings, dividend stocks remain an attractive option for those seeking steady income amidst market fluctuations. In this environment, a good dividend stock is characterized by its ability to offer consistent payouts and financial stability, providing investors with a reliable income stream even as broader economic conditions...

InMode (NASDAQ:INMD) has had a great run on the share market with its stock up by a significant 10% over the last week...

Cornerstone Bancorp (CNBP) closed out FY 2025 with fourth quarter total revenue of US$11.0 million and basic EPS of US$3.14, alongside net income of US$3.09 million that capped off a year of steady profitability. The company has seen quarterly revenue move from US$9.66 million in Q4 FY 2024 to US$11.0 million in Q4 FY 2025, while basic EPS over that same period went from US$3.02 to US$3.14, supported by a trailing twelve month net profit margin of 25.9% versus 25.7% a year earlier. Taken...

If you are wondering whether Alexander's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock most recently closed at US$239.55, with a 7 day return of 0.5% decline, a 30 day return of 9.8%, year to date return of 9.5%, and a 1 year return of 36.3%, which naturally raises questions about how much of this is already reflected in the price. These moves sit alongside a 3 year return of 27.7% and a 5...

If you are wondering whether Leidos Holdings at around US$187 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has delivered a 33.6% return over the past year and 96.3% over three years. More recently it has seen a 2.0% decline over 7 days and a 0.7% return over the last month, with a 2.0% return year to date. Investors have been paying close attention to Leidos because of its role as a major government and defense...

If you are wondering whether Denali Therapeutics' current share price lines up with its underlying worth, this review will walk through what the numbers are actually saying about value. The stock last closed at US$21.25, with returns of 21.2% over 7 days, 26.0% over 30 days, 30.6% year to date, but a 9.6% decline over 1 year, a 29.8% decline over 3 years, and a 70.8% decline over 5 years, which can change how investors think about both opportunity and risk. Recent attention on Denali...

If you are wondering whether Hubbell's current share price lines up with its underlying worth, you are not alone. This article is here to walk you through that question step by step. Hubbell shares last closed at US$484.14, with returns of 2.5% over 7 days, 6.4% over 30 days, 4.6% year to date, 18.7% over 1 year, 120.5% over 3 years, and 232.0% over 5 years, which naturally raises questions about what you are paying for today. Recent attention on Hubbell has been driven by ongoing investor...

Shareholders of Kenvue (NYSE:KVUE) are preparing to vote on a proposed sale of the company to Kimberly-Clark. The deal structure includes a mix of cash and Kimberly-Clark shares for Kenvue investors. Proxy advisory firms have recommended that shareholders back the transaction ahead of the vote. The proposal has drawn extra attention because litigation tied to Kenvue products is still ongoing. Kenvue, the consumer health company separated from Johnson & Johnson, sits at the intersection of...

If you are wondering whether Kinsale Capital Group's current share price reflects its true worth, you are not alone in asking that question. The stock recently closed at US$386.67, with returns of a 4.6% decline over 7 days, a 1.7% decline over 30 days, a 1.5% decline year to date, gains of 39.5% over 3 years and 108.3% over 5 years, while the last 12 months show a 12.4% decline. Recent attention around Kinsale Capital Group has focused on its share price performance and how investors are...

Analysts are raising concerns that expiring Medicare telehealth reimbursement provisions could change how at-home virtual care visits are paid for, affecting Teladoc Health's (NYSE:TDOC) revenue mix. At the same time, BetterHelp, Teladoc's online therapy platform, is seeing a drop in monthly active users that analysts link to softer consumer sentiment. Together, these reimbursement questions and user trends are putting fresh attention on Teladoc's demand outlook across both medical and...

If you are wondering whether Costamare's current share price reflects its true worth, you are not alone. Many investors are asking the same question. Costamare's stock recently closed at US$16.33, with returns of 5.8% over 7 days, 3.9% over 30 days, 4.1% year to date, 98.0% over 1 year, 145.6% over 3 years and 241.2% over 5 years. Recent news around the container shipping and broader transportation sector has kept attention on companies like Costamare, as investors weigh supply chain trends,...

Corvus Pharmaceuticals reported positive Phase 1 results for soquelitinib in moderate to severe atopic dermatitis, including patients who had limited response to prior therapies. The trial showed encouraging efficacy and safety data, prompting the company to outline plans for a larger Phase 2 study. Corvus expects to begin enrolling patients in the Phase 2 trial in early 2026. For investors tracking Corvus Pharmaceuticals, ticker NasdaqGM:CRVS, this update comes with the stock at $22.08 and...

WEX (NYSE:WEX) has launched a single fleet card that can be used for both traditional fuel purchases and public EV charging. The company has also entered a virtual card partnership with Nuvei to serve global travel merchants. For investors tracking NYSE:WEX, these product moves come with the stock trading at $156.7. Recent returns show a mixed picture, with the share price up 3.2% over the past week and 5.6% year to date, but with a 1-year return of a 13.7% decline and a 3-year return of a...